to explore results)
- Drug Discovery for Psychiatric Disorders, CHAPTER 10 Glutamate Approaches Towards the Treatment of Mood Disorders.
, Pages 258-275
- Drug Discovery for Leishmaniasis, Chapter 8 Medicinal Chemistry Strategies to Discover New Leishmanicidal Drugs.
, Pages 153-178
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 9 Heterocycles Containing Nitrogen and Sulfur as Potent Biologically Active Scaffolds.
, Pages 231-261
- Orphan Drugs and Rare Diseases, Chapter 11 Drug Discovery Approaches for Rare Neuromuscular Diseases.
, Pages 257-343
- Nuclear Magnetic Resonance: Volume 40, NMR in living systems.
, Volume 40
, Pages 472-533
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 1 Overview of Molecular Chaperones in Health and Disease.
, Pages 1-36
- Neurodegeneration: Metallostasis and Proteostasis, Chapter 11 Metal Toxicity and Metallostasis in Amyotrophic Lateral Sclerosis.
, Pages 226-248
- Nanostructured Biomaterials for Overcoming Biological Barriers, Chapter 7.3 Drug Delivery Strategies: Nanostructures for Improved Brain Delivery.
, Pages 392-432
- Inhibitors of Molecular Chaperones as Therapeutic Agents, Subject Index
, Pages 414-425
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Subject Index
, Pages 459-468